Health News

Blood Donor? Check Your Iron Levels
Giving blood can be a selfless act that can save lives, but it may also affect the donor's health if it's done too frequently.
First Drug Approved to Treat Waldenström’s Macroglobulinemia
The U.S. Food and Drug Administration today expanded the approved use of Imbruvica (ibrutinib) for patients with Waldenström’s macroglobulinemia (WM), a rare form of cancer that begins in the body’s immune system.
New Rx Approved for Low Blood Calcium
The U.S. Food and Drug Administration approved Natpara (parathyroid horomone) to control hypocalcemia (low blood calcium levels) in patients with hypoparathyroidism, a rare disease that affects approximately 60,000 people in the United States.
Great Leaps in Leukemia Treatment
Cancer research has led to longer lives and better quality of life for millions of people. This year, the transformation of leukemia treatment has been singled out as the “Advance of the Year.”
FDA Approves Anti-Clotting Drug Savaysa
The U.S. Food and Drug Administration today approved the anti-clotting drug Savaysa (edoxaban tablets) to reduce the risk of stroke and dangerous blood clots (systemic embolism) in patients with atrial fibrillation that is not caused by a heart valve problem.
FDA Approves Pathogen Reduction System to Treat Platelets
The U.S. Food and Drug Administration yesterday approved the Intercept Blood System for platelets, the first pathogen reduction system to treat single donor apheresis platelets.
Amgen's Leukemia Rx is Effective & Expensive
Earlier this month, the US Food and Drug Administration (FDA) approved a new type of treatment for a severe form of leukemia. That treatment becomes available Thursday, and the manufacturer has revealed how much it will cost.
Quality of Life May Raise Quantity of Life With Lymphoma
Feeling good about life may make it last a little longer. Lymphoma patients with high quality of life may live longer than those with lower life satisfaction.
FDA Approves First Test for Group of Human Retroviruses
The U.S. Food and Drug Administration today approved MP Diagnostics HTLV Blot 2.4, the first FDA-licensed supplemental test for Human T-cell Lymphotropic Virus-I/II (HTLV-I/II).
Rx Combo Slowed Multiple Myeloma
When it comes to treating multiple myeloma, three medications may be better than two.